Propaten (heparin bonded) grafts for haemodialysis access: Is there any advantage?  by Khalid, Usman et al.
Abstracts / International Journal of Surgery 11 (2013) 686e745734
ABSTRACTSrecommend taking at least 10mm in length in order to minimise the false
negative rate.
Methods: A retrospective audit was carried out for biopsies performed
over a 12 month period at a single centre by the vascular surgery
department. Specimen length and histological ﬁndings were reported by
Consultant Histopathologists.
Results: 52 biopsies were included in the study and 35/52 (67.3%) were
10mm or greater in length. The mean specimen length was greater in
positive biopsies (15.8mm) compared with negative biopsies (10.9mm)
and increased with grade of surgeon, SHO (n¼6), 9.7mm; SpR (n¼36),
10.39mm; Consultant (n¼9), 11.3mm. Themean ESR was higher in patients
whose specimens were less than 9mm (n¼19), 45.1 compared to those
with specimens 10mm or greater (n¼33), 36.8. Specimens less than 9mm
were more likely to be "non-arterial tissue" (21.1%) compared with spec-
imens 10mm or greater (3.0%).
Conclusion: The majority of specimens were 10mm or greater in length
but there is still room for improvement in practice. The more experienced
surgeons took longer biopsies, and shorter biopsy specimen length was
associated with non-arterial tissue sampling and raised ESR.
0131: SURGICAL AND FUNCTIONAL OUTCOMES AFTER THORACIC
OUTLET SYNDROME DECOMPRESSION VIA SUPRACLAVICULAR
APPROACH: A 10-YEAR SINGLE CENTRE EXPERIENCE
Jakub Kaczynski, Steve Atherton, Louis Fligelstone. ABM University Health
Board, Vascular Surgery Department, Morriston Hospital, Swansea, UK.
Aim: The aimwas to assess surgical and functional outcomes after surgical
decompression of the thoracic outlet using the Disabilities of the Arm,
Shoulder and Hand (DASH) questionnaire.
Methods: A retrospective review of all thoracic outlet syndrome (TOS)
cases operated between 2002- 2012. The pre and post operative DASH
questionnaire scores were recorded.
Results: Forty four patients (88%) completed pre and post operative DASH
questionnaire. Mean age was 42+ 10.78 years and 37 were women. There
were 40 elective and 4 emergency operations. Decompressive procedures
consisted of an excision of the cervical (n¼11) or ﬁrst rib (n¼23), combined
cervical and ﬁrst rib excision (n¼10), scalenectomy (n¼42) and division of
soft tissue (n¼24). Post operative complications included wound infection
(n¼1), phrenic nerve traction injury (n¼2) and pleural entries (n¼12).
Mean follow up was 11.7+ 15.4 months. The most marked post operative
improvement was noted in arterial TOS with mean delta change of 36.99+
22.72 (p¼0.005), followed by venous TOS (26.22+ 16.89, p¼0.026) and
neurogenic TOS (18.64+ 21.07, p¼0.015). Thirty nine (78%) patients re-
ported the return of upper limb function.
Conclusions:Careful selection of patientswithmeticulous surgical technique
can produce excellent surgical and functional outcomes in all TOS types.
0164: PROPATEN (HEPARIN BONDED) GRAFTS FOR HAEMODIALYSIS AC-
CESS: IS THERE ANY ADVANTAGE?
Usman Khalid, Paula Davies, Kamran Mohiuddin, Chris Davies,
Justin Woolgar. Department of Vascular Surgery, Morriston Hospital,
Swansea, UK.
The use of an Arterio-venous synthetic graft (AVG) for haemodialysis ac-
cess is often necessary if the veins become thrombosed or are of small
calibre. The aim of this audit was to determine the outcomes of the hep-
arin-bonded Propaten (WG Gore Phoenix Arizona) graft.
All patients who had Propaten AVG inserted between January 2011 and
December 2012 were included in this study. Theatre records and clinical
notes were interrogated retrospectively to collect data on indication for
Propaten AVG, its location, patency and any complications.
Twenty ﬁve patients had Propaten AVG inserted over the 2-year period,
68% were female, and the median age was 66 (22-86). Indication for the
use of AVG was the lack of any suitable veins (either thrombosed or
diameter less than 3mm). The most common location was brachio-basilic
AVG (60%). 56% of the patients were successfully dialysing using these
AVG's at the time of study or time of death. There was primary failure in
28% and one graft was removed at 6 months due to infection.
Patency rates are comparable to other synthetic grafts and the heparin
bonded Propaten graft appears to confer no advantage. Furthermore there
is a signiﬁcant cost implication with the use of Propaten.0245: IS DUPLEX ULTRASOUND ENDOLEAK SURVEILLANCE AFTER EVAR
COST EFFECTIVE? A COMPARISON WITH EUROPEAN SOCIETY OF
VASCULAR SURGERY GUIDELINES
Jon Grifﬁn, Rachel S. Williams, Mark Pemberton. Queen Alexandra Hospital,
Portsmouth, UK.
Aims: To compare the cost effectiveness of our department's predomi-
nantly duplex ultrasound (DUS) based post-EVAR surveillance program
with that recommended by the European Society of Vascular Surgery
guideline that relies more heavily on CT angiogram (CTA) surveillance.
Methods: The clinical records and surveillance imaging of 100 consecutive
patients post-EVAR were reviewed. The total cost of imaging they received
during the follow up period was compared with the total cost of imaging
according to ESVS guidelines. The 2012/13 NHS cost tariffs for CTA (£130/
scan) and DUS (£47/scan) were used.
Results: Over ﬁve years follow up, 417 episodes of imaging occurred (252
DUS, 165 CTA). Use of CTA decreased from 99% at one-month follow up to
33% at one year. Thereafter up to 27% of patients required CTA at any
subsequent follow up. Total cost of imaging in our program was £33,294
(CTA: £21,450, DUS £11,844). The ESVS guidelines were applied to our data
set. This hypothetical scenario would have cost £35,792 comprising 237
CTA (£30,810) and 106 DUS (£4,982). Our DUS surveillance program saved
£2,498 over 5 years.
Conclusions: CTA surveillance is more expensive than DUS post EVAR
even when shorter DUS surveillance intervals are used.
0249: GREATER THAN TEN-YEAR OUTCOMES FOLLOWING ENDOVASCU-
LAR ANEURYSM REPAIR
Laura Warner 2, Hannah Sevenoaks 1, Jonathan Ghosh 1. 1University
Hospitals of South Manchester, Manchester, UK; 2North Western Deanery,
North West, UK.
Aims: Endovascular aneurysm repair (EVAR) offers improved periopera-
tive morbidity and mortality compared to open repair, counterbalanced by
a higher incidence of graft-related complications and re-interventions.
Randomised studies comparing EVAR to open repair are yet to report
greater than ten-year outcomes. This study reports the outcomes of pa-
tients who underwent EVAR with ﬁrst generation endografts greater than
ten years ago.
Methods: Retrospective review of prospectively collected data of all pa-
tients who underwent EVAR between 1997 and 2001, supplemented with
case note review, interrogation of imaging and correspondence with
general practitioners and coroners' ofﬁces.
Results: 58 patients underwent EVAR. Technical success was 100% and 30-
day mortality was 0%. The re-intervention rate was 27.3%, including 5
elective open conversions, 2 emergency open repairs, 5 embolizations, and
3 extensions. Median time to re-intervention was 30 months (1-144). Four
patients died from ruptured AAA.
Conclusions: Stable long-term aneurysm exclusion was achieved in the
majority of patients. Virtually all re-interventions were performed within
50 months. Whilst life-long surveillance should be continued, these data
raise the question of the appropriate duration of CT surveillance and
suggests that EVAR should be considered for patients with longer life ex-
pectancy and favourable anatomy who traditionally would have under-
gone open repair.
0270: POST-OPERATIVE MANAGEMENT OF DIABETIC PATIENTS
REQUIRING MAJOR AMPUTATION IS MORE CHALLENGING THAN THOSE
HAVING OPEN ABDOMINAL AORTIC ANEURYSM SURGERY (AAA)
Mohamed Barkat, Nathan Appleton, Rajesh Chatha, Colin Chan. Wirral
University Teaching Hospital NHS Foundation Trust, Wirral, UK.
Aim: In-hospital mortality rates for patients undergoing diabetic foot
surgery range from 9% (National Vascular Database) to 17% (Hospital
Episode Statistics data). This compares unfavourably with 4% for that of
open AAA surgery. Our aim was to evaluate outcomes following major
diabetic foot amputations in a district general hospital.
Method: A retrospective case note review of consecutive patients under-
going major amputation for diabetic foot complications over a three year
period.
Results: Between August 2009 to August 2011, 75 patients underwent
major amputations: (50% trans-femoral, 42% trans-tibial and 8% other).
